Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 34 publications
Lessons learned from clinical trials of thymic stromal lymphopoietin (TSLP) inhibition.
Journal: The Journal of allergy and clinical immunology
Published: May 28, 2026
Pharmacokinetics and safety of tezepelumab in children with mild, moderate or severe asthma and adolescents with mild-to-moderate asthma.
Journal: British journal of clinical pharmacology
Published: December 23, 2025
AZD8630/AMG 104, an inhaled anti-thymic stromal lymphopoietin antibody fragment, for moderate-to-severe asthma: Phase 1 randomized controlled trial.
Journal: The Journal of allergy and clinical immunology
Published: November 28, 2025
Safety, Pharmacokinetics, and Immunogenicity of Astegolimab, an Anti-ST2 Monoclonal Antibody, in Randomized, Phase I Clinical Studies.
Journal: Clinical and translational science
Published: March 11, 2025
Distinct roles for thymic stromal lymphopoietin (TSLP) and IL-33 in experimental eosinophilic esophagitis.
Journal: bioRxiv : the preprint server for biology
Published: March 10, 2025
Anti-KIT antibody, briquilimab, induces mast cell apoptosis and depletion in nonhuman primates.
Journal: The Journal of allergy and clinical immunology
Published: February 12, 2025
Tezepelumab can Restore Normal Lung Function in Patients with Severe, Uncontrolled Asthma: Pooled Results from the PATHWAY and NAVIGATOR Studies.
Journal: Pulmonary therapy
Published: December 18, 2024
Asthma Biologics Across the T2 Spectrum of Inflammation in Severe Asthma: Biomarkers and Mechanism of Action.
Journal: Journal of asthma and allergy
Published: October 11, 2024
Tezepelumab and Mucus Plugs in Patients with Moderate-to-Severe Asthma.
Journal: NEJM evidence
Published: February 06, 2024
A GIPR antagonist conjugated to GLP-1 analogues promotes weight loss with improved metabolic parameters in preclinical and phase 1 settings.
Journal: Nature metabolism
Published: October 13, 2023
Last Updated: 09/26/2026